{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:59:47Z","timestamp":1778857187718,"version":"3.51.4"},"reference-count":20,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"3","license":[{"start":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T00:00:00Z","timestamp":1590537600000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In light of the ongoing opioid crisis, many have encouraged the medical community as well as local and national US government agencies to reconsider the prevalent use of benzodiazepines. As prescribers continue to weigh the risks and benefits of ongoing benzodiazepine use, care must be taken when the decision is made to taper and discontinue these medications in patients who have been maintained on them chronically. We present a case of an adult patient maintained on a benzodiazepine for several years who developed tinnitus during a gradual dose taper. This patient developed tinnitus within 7 weeks of gradual reduction of the patient's clonazepam dose to 50% of the original dose in an outpatient clinic. The persistence of these symptoms prevented further dose reductions. Upon review of the available literature, several other cases were identified describing development of tinnitus upon discontinuation or tapering of a benzodiazepine. In weighing the risks and benefits of chronic benzodiazepine therapy, tinnitus must be considered as a rare but debilitating and long-term risk of benzodiazepine withdrawal. Providers must be prepared to individualize benzodiazepine tapers and be vigilant about emergence of withdrawal symptoms to prevent undue stress in patients.<\/jats:p>","DOI":"10.9740\/mhc.2020.05.100","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T20:12:53Z","timestamp":1588882373000},"page":"100-103","source":"Crossref","is-referenced-by-count":9,"title":["Tinnitus associated with benzodiazepine withdrawal syndrome: A case report and literature review"],"prefix":"10.9740","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9639-0979","authenticated-orcid":false,"given":"Corey","family":"Laskey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7508-514X","authenticated-orcid":false,"given":"Brandon","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"key":"2020060309444495000_i2168-9709-10-3-100-b01","article-title":"Clonazepam [package insert]","year":"2008"},{"key":"2020060309444495000_i2168-9709-10-3-100-b02","article-title":"Diazepam [package insert]","year":"2018"},{"key":"2020060309444495000_i2168-9709-10-3-100-b03","unstructured":"Alprazolam [package insert]. Weston (FL): Apotex Corp; 2017."},{"key":"2020060309444495000_i2168-9709-10-3-100-b04","article-title":"Lorazepam [package insert]","year":"2010"},{"issue":"4","key":"2020060309444495000_i2168-9709-10-3-100-b05","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"2020060309444495000_i2168-9709-10-3-100-b06","article-title":"FDA drug safety communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning","author":"US Food and Drug Administration","year":"2016"},{"issue":"8","key":"2020060309444495000_i2168-9709-10-3-100-b07","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2020060309444495000_i2168-9709-10-3-100-b08","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2013United States, 2016. MMWR Recomm","volume":"65","author":"Dowell","year":"2016","journal-title":"Rep"},{"key":"2020060309444495000_i2168-9709-10-3-100-b09","article-title":"Re-evaluating the use of benzodiazepines: a focus on high-risk populations","author":"US Department of Veterans Affairs, Pharmacy Benefits Management, National Academic Detailing Service","year":"2020"},{"issue":"1","key":"2020060309444495000_i2168-9709-10-3-100-b10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11920-015-0642-5","article-title":"Withdrawing benzodiazepines in patients with anxiety disorders","volume":"18","author":"Lader","year":"2016","journal-title":"Curr Psychiatry Rep"},{"issue":"10","key":"2020060309444495000_i2168-9709-10-3-100-b11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines II. Effects of gradual taper","volume":"47","author":"Schweizer","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"6424","key":"2020060309444495000_i2168-9709-10-3-100-b12","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/bmj.288.6424.1135","article-title":"Benzodiazepine withdrawal: an unfinished story","volume":"288","author":"Ashton","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"14","key":"2020060309444495000_i2168-9709-10-3-100-b13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1056\/NEJM198610023151403","article-title":"Withdrawal reaction after long-term therapeutic use of benzodiazepines","volume":"315","author":"Busto","year":"1986","journal-title":"N Engl J Med"},{"issue":"5","key":"2020060309444495000_i2168-9709-10-3-100-b14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00004714-198810000-00010","article-title":"Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines","volume":"8","author":"Busto","year":"1988","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"2020060309444495000_i2168-9709-10-3-100-b15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation","volume":"47","author":"Rickels","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"9904","key":"2020060309444495000_i2168-9709-10-3-100-b16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/S0140-6736(13)60142-7","article-title":"Lancet","volume":"382","author":"Baguley","year":"2013"},{"issue":"10","key":"2020060309444495000_i2168-9709-10-3-100-b17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/jnnp-2013-307339","article-title":"The neuropsychiatry of tinnitus: a circuit-based approach to the causes and treatments available","volume":"85","author":"Minen","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"2020060309444495000_i2168-9709-10-3-100-b18","first-page":"98","article-title":"Benzodiazepine receptor deficiency and tinnitus","volume":"6","author":"Shulman","year":"2000","journal-title":"Int Tinnitus J"},{"issue":"8","key":"2020060309444495000_i2168-9709-10-3-100-b19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/jnnp-2012-302273","article-title":"Clonazepam quiets tinnitus: a randomised crossover study with gingko biloba","volume":"83","author":"Han","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2 Suppl","key":"2020060309444495000_i2168-9709-10-3-100-b20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599814545325","article-title":"Clinical practice guideline: tinnitus","volume":"151","author":"Tunkel","year":"2014","journal-title":"Otolaryngol Head Neck Surg"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/10\/3\/100\/2494449\/mhc_2020_05_100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/10\/3\/100\/2494449\/mhc_2020_05_100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:19:09Z","timestamp":1731687549000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/10\/3\/article-p100.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2020.05.100","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}